Optimism is returning to Trinidad and Tobago after years of recession. With the IMF forecasting GDP expansion of 1% in 2018 and 0.9% in 2019, the government now has the opportunity to shift their focus from tackling short-term economic problems to implementing long-term reforms and policy initiatives.
New policies encouraging the use of generic drugs are set to reduce the cost of health care in Abu Dhabi, which is likely to attract more investment to the pharmaceuticals manufacturing industry.
Although Papua New Guinea’s macroeconomic slowdown, challenging business climate and falling global commodity prices have weighed on trade and investment in recent years, the country continues to offer high-potential opportunities to investors.
Interviews & Viewpoints | Florencia Davel, CEO, Bristol-Myers Squibb Argentina, Chile and Peru: Interview from The Report: Argentina 2018
How will collaboration between international and local institutions help develop the sector?
Articles & Analysis | Argentina tackles challenges of a decentralised health system from The Report: Argentina 2018
The Argentine health care system is divided into three subsectors. The public sector assists both those citizens without health insurance, mainly from low-income backgrounds, and includes public hospital provision while also providing health plans for retirees and government employees at a national and provincial level, including...
Articles & Analysis | Demand for pharmaceutical products is rising globally from The Report: Argentina 2018
In recent decades, the pharmaceutical market has expanded its geographical reach. This trend appears to be here to stay; in a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy& team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging...